gms | German Medical Science

71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

21.06. - 24.06.2020

Investigating cerebral reorganisation in degenerative cervical myelopathy – a prospective, multi-centre trial

Die Untersuchung der zerebralen Reorganisation bei degenerativer zervikaler Myelopathie – eine prospektive, multizentrische Studie

Meeting Abstract

  • presenting/speaker Anna Zdunczyk - Charité – Universitätsmedizin Berlin, Klinik für Neurochirurgie, Berlin, Deutschland
  • Leona Kawelke - Charité – Universitätsmedizin Berlin, Klinik für Neurochirurgie, Berlin, Deutschland
  • Sebastian Ille - Technische Universität München, Klinik für Neurochirurgie, München, Deutschland
  • Sandro Krieg - Technische Universität München, Klinik für Neurochirurgie, München, Deutschland
  • Carolin Weiß Lucas - Universitätsklinikum Köln, Klinik für Neurochirurgie, Köln, Deutschland
  • Thomas Picht - Charité – Universitätsmedizin Berlin, Klinik für Neurochirurgie, Berlin, Deutschland
  • Peter Vajkoczy - Charité – Universitätsmedizin Berlin, Klinik für Neurochirurgie, Berlin, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie. sine loco [digital], 21.-24.06.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. DocV170

doi: 10.3205/20dgnc167, urn:nbn:de:0183-20dgnc1678

Veröffentlicht: 26. Juni 2020

© 2020 Zdunczyk et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: The concept of "Cortico-spinal Reserve in patients suffering from degenerative cervical Myelopathy" (CReMe) has been recently introduced. In patients suffering from mild symptoms (JOA>12) and thus preserved reserve an enlarged motor area due to a higher recruitment of supplementary motor areas (M2) was observed. In contrast, severely symptomatic patients (JOA<12) with an exhausted reserve presented with a restricted motor area, reduced recruitment curve and increased inhibition. The current prospective multicentre trial has been designed to validate the new pathophysiological concept.

Methods: In our on-goingtrial, we have enrolled 120 patients with degenerative cervical myelopathy (DCM) from 4 spine centres in Germany and Switzerland. The study was sponsored by a DWG research grant. On the basis of the initial Japanese Orthopaedic Association (JOA) Score three patient groups were established (JOA≤12, 13-15, 15-17). Corticospinal excitability was determined by navigated transcranial magnetic stimulation (nTMS) with the following parameters: Resting motor threshold (RMT), Recruitment curve (RC), Cortical silent period (CSP) and Motor area.

Results: In patients with moderate symptoms (JOA 12-15) we encountered a compensatory increase of motor cortex activation (motor area: p<05; mean ± SD JOA 12-15: 308,5 ± 213,3 vs. JOA ≤ 12: 225,7 ± 159,5) and maintained corticospinal excitability (RC slope p=0.4; JOA 12-15: 10,6 ± 6 vs. JOA 15-17: 11,1 ± 5,2). In contrast patients with severe symptoms (JOA ≤12) presented a reduced excitability of cortico-cortical axons reflected by an elevated RMT (p<0.05; JOA ≤12: 43,8 ± 11,4 vs. JOA 15-17: 39,2 ± 8,4) and reduced corticospinal excitability expressed by a lower RC slope (p<0.05; JOA ≤12: 8,4 ± 4,8 vs. JOA 15-17: 11,1 ± 5,2). The diminished cortical motor area (p<0.05, see above) further revealed a functional restriction on the cortical level in this group.

Conclusion: In summary our prospective multicentre trial has confirmed our concept for functional reorganization in patients suffering from DCM i.e. the "corticospinal reserve capacity". It became apparent that the individual pattern of compensation is a sensitive marker to objectify the state of the disease and may indicate imminent non-reversible clinical deterioration. This innovative approach to describe the pathomechanisms in DCM might revise current concepts of clinical diagnostics and might have an impact on future treatment strategies.